Provided by Tiger Trade Technology Pte. Ltd.

Kodiak Sciences Inc.

94.26
+3.183.49%
Post-market: 94.390.1255+0.13%19:52 EDT
Volume:1.53M
Turnover:142.07M
Market Cap:5.90B
PE:-22.67
High:94.95
Open:90.01
Low:89.54
Close:91.08
52wk High:104.00
52wk Low:10.94
Shares:62.58M
Float Shares:36.99M
Volume Ratio:0.61
T/O Rate:4.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1571
EPS(LYR):-4.3220
ROE:-368.37%
ROA:-60.45%
PB:96.55
PE(LYR):-21.81

Loading ...

Kodiak Sciences to Present Phase 3 Daybreak Wet AMD Data for Zenkuda at AAO 2026

Reuters
·
Oct 07

Kodiak Sciences Stock Pick of the Week at Smart Insider Following Insider Share Purchase

MT Newswires Live
·
Oct 06

Movement Alert|Kodiak Sciences Inc. Intraday Decline 5.09%, Profit-Taking Pressure Emerges After Key Data Release

Market Focus
·
Oct 05

Analysts Are Bullish on Top Healthcare Stocks: Liquidia Technologies (LQDA), Kodiak Sciences (KOD)

TIPRANKS
·
Oct 05

Movement Alert|Kodiak Sciences Inc. Declines 5.08% in Regular Trading, Trading at $93.76

Market Focus
·
Oct 02

Learn Why The Bull Case For Kodiak Sciences Stock Could Change Following Late Stage Eye Disease Trial Win

Simply Wall St.
·
Oct 02

Canaccord Genuity Sticks to Their Buy Rating for Kodal Minerals (KOD)

TIPRANKS
·
Oct 02

Movement Alert|Kodiak Sciences Inc. Rises 6.9% in Regular Trading, Major Shareholder Baker Brothers Adds Over 350,000 Shares

Market Focus
·
Oct 01

Form 4 | Kodiak Sciences directors and 10% owners Felix Baker and Julian Baker, via funds, purchased ~359,000 common shares (P).

Filings Track
·
Oct 01

Kodiak Sciences Inc. Director Felix J. Baker purchased 227,671 shares.

Filings Track
·
Oct 01

Kodiak Sciences Inc. Director Felix J. Baker acquired 639,386 shares.

Filings Track
·
Oct 01

Baker Bros. Advisors Buys $32.31 Million of Kodiak Sciences Common Shares

Reuters
·
Oct 01

Movement Alert|Kodiak Sciences Inc. Rises 6.48% in Regular Trading, Phase 3 Clinical Success Continues to Lift Shares

Market Focus
·
Sep 30

Kodiak Sciences Inc. : JP Morgan Raises Target Price to $124 from $69

THOMSON REUTERS
·
Sep 29

Movement Alert|Kodiak Sciences Inc. Falls 5.21% in Regular Trading, Pullback After 146% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

Movement Alert|Kodiak Sciences Inc. Falls 5.36% in Pre-Market Trading, Profit-Taking After 172% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

US Research Roundup-Acuity, Dell Technologies, Nike

Reuters
·
Sep 29

Movement Alert|Kodiak Sciences Inc. Falls 7.83% Overnight, Retreating After 146% Surge on Phase 3 Trial Success

Market Focus
·
Sep 29

NASD Most Active Issues

Dow Jones
·
Sep 29

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Reuters
·
Sep 29